Meanwhile, PPAR-γ activator supplementation has been shown to increase HSPA1 mRNA and protein levels in the atria of an AF rat model, inhibit age-related arrhythmogenic atrial remodeling, and AF perpetuation by improving antioxidant capacity and inhibiting the mitochondrial apoptotic signaling pathway [32]. The gene discussed is PPARG; the disease is atrial fibrillation.